and a Phase 2b ulcerative colitis study (ANTHEM-UC). Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera.
As initial production continues at the expandable graphite joint venture operations near Pune in India, Evion Group NL (ASX:EVG, OTC:EVIGF) is readying for another key milestone with first shipments ...